ANI PHARMACEUTICALS INC — Director's Dealing 2020

Apr 1, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2020-03-28

Reporting Person: Schrepfer Robert W (SVP - New Bus Dev & Spec Sales)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-28	Common Stock	F	1037	$37.76	Disposed	54890	Direct
2020-03-31	Common Stock	F	552	$40.74	Disposed	54338	Direct

Footnotes

F1: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,112 shares of restricted stock, which was previously reported.

F2: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,656 shares of restricted stock, which was previously reported.